Results 241 to 250 of about 107,475 (276)

Narcolepsy initially misdiagnosed as schizophrenia: A case report

Sleep Research, EarlyView.
Feng Daoyi, Liu Xin, Xu Rui, He Lihua
wiley   +1 more source

Is Addiction Research Addicted to Artificial Intelligence? Mapping the Intersection of Artificial Intelligence, Substance Use and Mental Health Through a Bibliometric Analysis. [PDF]

Drug Alcohol Rev
Vanhée L, Scarpa S.
europepmc   +1 more source

Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial.

JAMA Psychiatry
Goutham S, Bhargav H, Holla B, Mahadevan J, Nagendra RP, Jasti N, Narasimha VL, Mehta UM, Varambally S, Venkatasubramanian G, Chand P, Gangadhar BN, Hill KP, Keshavan M, Murthy P.   +14 more
europepmc   +1 more source

The role of pharmacogenomics in the discontinuation of psychotropic medication: a scoping review protocol. [PDF]

HRB Open Res
Stollarova N, Ryan C, Sheaf G, Keating D, O'Donoghue B, Cadogan C.   +5 more
europepmc   +1 more source

The Effects of Orexin Receptor Antagonism During Early Withdrawal in Stimulant Use Disorder: Protocol for a Proof-of-Concept Study.

JMIR Res Protoc
Webber H, Tran N, Blake R, Goldman S, George T, Bailey B, Suchting R, Yoon J, Vincent J, Weaver M, Schmitz J, Lane S.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacological management of psychoactive substance withdrawal syndrome

Drugs & Therapy Perspectives, 2021
Medications are available to manage alcohol and drug withdrawal, but they are underutilized. Only a handful, such as methadone, buprenorphine, clonidine, or benzodiazepines (chlordiazepoxide, lorazepam, or diazepam), are prescribed. Our objective was to provide an adjusted, inclusive, critical review of the clinical benefits of medications studied for ...
Dimy Fluyau, Sarah Clare Cook, Ashmeer Chima, Vasanth Kattalai Kailasam, Neelambika Revadigar   +4 more
openaire   +1 more source